TR-1177 Not verifiedRecorded November 2026
Tirzepatide
Recorded for AlyveRx · Sublingual · every tirzepatide record
Price
Historical price evidence from November 2026. Current availability and prices are not verified. These figures are not a current offer.
| Term | Published rate | Charged today |
|---|---|---|
| Tirzepatide sublingual starting figure Price conditions have not been established; the quoted figure is not a verified recurring rate. Published starting figure; applicable dose, initial payment and renewal terms are not established by this headline. “From $249/mo” | $249Published figure | Charged todayNot verified |
Price sources
- Tirzepatide sublingual starting figure · alyverx.com — read November 2026
Provider website · AlyveRx
Current availability of this program is not verified.
We earn nothing from this link. It opens AlyveRx's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- November 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Assigned dispensing pharmacy not disclosed. The terms describe network fulfillment and a patient-selected pharmacy option without naming the assigned dispenser. |
|---|---|
| States | Complete medication-specific eligible-state roster not disclosed. Eligibility depends on location and clinician licensure; no complete state list is provided. |
| Prescriber | Required consultation format not disclosed. Assessment and provider review do not establish whether synchronous or asynchronous care is required. |
| Cancellation | For plans sold as subscriptions, renewal continues until canceled before the next billing date. Processed medication orders are generally nonrefundable; exceptions may apply for damage, loss in transit or treatment unavailability. If prescribed treatment becomes unavailable due to supply, regulatory or other circumstances outside the company’s control, the unshipped portion of a prepaid plan may qualify for a prorated refund; approved refunds are processed within 30 days. An appropriate alternative or platform credit may also be requested. The subscription clause contains a support-email placeholder, while section 21 and the footer list support@alyverx.com. |
| Membership | Separate membership charge not disclosed. No itemized membership fee or explicit no-membership statement is established for this offer. |
| Consult fee | Separate consultation charge not disclosed. A provider review is described without an itemized consultation charge. |
Recorded from alyverx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. November 2026 — Alyve, Inc. describes itself as a clinical infrastructure and managed-services platform. Independent licensed clinicians make medical decisions; partner pharmacies fulfill prescriptions. A public assessment followed by provider review does not establish whether a live consultation is required. Sources: https://www.alyverx.com/terms-of-service.
- 2. November 2026 — The terms describe a cash-pay service outside commercial insurance, Medicare and Medicaid. No insurance claim or prior-authorization submission is provided by the platform. HSA/FSA acceptance and laboratory requirements or charges are not established in the reviewed pages. Sources: https://www.alyverx.com/terms-of-service.
- 3. November 2026 — Services require adulthood and physical presence in a state where the treating provider is licensed; some services require age 21. No complete medication-specific state roster is published, and testimonial locations are not coverage evidence. Sources: https://www.alyverx.com/terms-of-service.
- 4. November 2026 — The terms describe a pharmacy network and allow requesting a pharmacy of the patient’s choice, without naming the dispenser assigned to this program. Sources: https://www.alyverx.com/terms-of-service.
- 5. November 2026 — The product page advertises free expedited shipping and a less-than-48-hours delivery statement following approval; individual shipment timing is not verified. Sources: https://www.alyverx.com/products/tirzepatide-sublingual-drops.
- 6. November 2026 — For plans sold as subscriptions, renewal continues until canceled before the next billing date. Processed medication orders are generally nonrefundable; exceptions may apply for damage, loss in transit or treatment unavailability. If prescribed treatment becomes unavailable due to supply, regulatory or other circumstances outside the company’s control, the unshipped portion of a prepaid plan may qualify for a prorated refund; approved refunds are processed within 30 days. An appropriate alternative or platform credit may also be requested. The subscription clause contains a support-email placeholder, while section 21 and the footer list support@alyverx.com. Sources: https://www.alyverx.com/terms-of-service.
- 7. November 2026 — The terms say fees and recurring billing frequency are disclosed before purchase and prices may change. The public starting figure does not identify a selected dose, total enrollment payment or guaranteed renewal rate; separate membership and consultation charges are not established. Sources: https://www.alyverx.com/terms-of-service.
- 8. November 2026 — The dedicated product page and homepage explicitly list Tirzepatide Sublingual Drops with PermeAct delivery technology from $249 per month. This is a distinct named sublingual offering, not merely an educational mention. The page does not establish its compounded or branded formulation, so neither classification is assigned. Sources: https://www.alyverx.com/products/tirzepatide-sublingual-drops; https://www.alyverx.com/.
- 9. November 2026 — The tirzepatide drops product body advertises a starting figure of $249 per month, while its page title and structured product data show $329. Current formulation, selected payment and fulfillment require confirmation. Sources: https://www.alyverx.com/products/tirzepatide-sublingual-drops.
22 further notes concern other AlyveRx programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.